Queensland shines on global health stage as trade mission hits new level
- Crisafulli Government leads powerful Queensland delegation to India's BioAsia 2025.
- Trade mission to repair trade relationships which were left in tatters after a decade of the previous Labor Government.
- 20 delegates representing 10 Queensland companies and research institutions exhibit at the premier global health-tech and life sciences event.
The Crisafulli Government has led a powerful Queensland delegation at India's BioAsia 2025 to generate millions of dollars' worth of trade and investment for the state.
The Minister for Finance, Trade, Employment and Training Ros Bates led the delegation – which included The Governer of Queensland Her Excellency the Honourable Dr Jeannette Young AC PSM - to the exhibition which is one of the world's premier life sciences and health-tech events.
BioAsia 2025, in Hyderabad, India, brings together around 2000 global leaders from industry, research and government to display the latest breakthroughs in cutting-edge digital health technologies.
The delegation included 20 members representing 10 Queensland companies and research institutions, who reinforced the state's position as a global leader in the health sector.
The Crisafulli Government is delivering on repairing trade relationships after they were left in tatters due to a decade of Labor's mismanagement.
Minister for Finance, Trade, Employment and Training Ros Bates said the Crisafulli Government was rebuilding trust and putting exporters back in the game.
"The opportunity to showcase their innovations at BioAsia 2025 sends a clear signal that Queensland is open for business," Minister Bates said.
"The trade relationship between Queensland and two economic powerhouses in India and Singapore is vital to repair the damage done by a decade of Labor and fixing the state's skills shortage.
"I am delighted to support these Queensland exporters and institutions to a huge and eager Indian market and demonstrate our world-leading innovations in biopharmaceuticals, digital health, medical devices and advanced therapeutics."
